Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Bids all gone / Going back to .05

<< Previous

Bullboard Posts

Next >>

Comment by postie1on Jan 11, 2024 8:18am

123 Views

Post# 35820979

RE:RE:RE:RE:Bids all gone / Going back to .05

In case BorcayGuy does not answer, here is some food for thought
I believe the Sept. 14 news release mentions the buyers and that they wanted a full slate of products for a seamless transtition. Plus from that news release we should be in the right time frame?

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant